Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Calithera Biosciences, Inc. (CALA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/21/2022 |
3
| TAKEDA PHARMACEUTICAL CO LTD (10% Owner) has filed a Form 3 on Calithera Biosciences, Inc. |
| 11/09/2021 |
3
| Kuriakose Emil (CHIEF MEDICAL OFFICER) has filed a Form 3 on Calithera Biosciences, Inc. |
| 07/14/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/01/2019 |
3
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 3 on Calithera Biosciences, Inc. |
| 10/03/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/21/2017 |
3
| Wise Blake (Director) has filed a Form 3 on Calithera Biosciences, Inc. |
| 01/06/2017 |
3
| Wong Stephanie (VP, FINANCE) has filed a Form 3 on Calithera Biosciences, Inc. |
| 01/06/2017 |
3
| Parlati Francesco (VP, RESEARCH) has filed a Form 3 on Calithera Biosciences, Inc. |
| 08/11/2016 |
3
| JONES SUZY (Director) has filed a Form 3 on Calithera Biosciences, Inc. |
| 05/03/2016 |
3
| Orford Keith (SR. VP, CLINICAL DEVELOPMENT) has filed a Form 3 on Calithera Biosciences, Inc. |
|
|